FDA's Vaccine Advisory Panel goes behind the delay of vaccines for kids under five

The FDA abruptly canceled a meeting in February where its advisory panel was set to consider authorizing a COVID vaccine for kids under age five. The move was a gut punch to parents who've been anxiously waiting for the chance to vaccinate their youngest children too. We talked with doctor Arnold Monto, the chair of that advisory panel, about what happened behind the scenes and why he thinks it was the right call.